Physicians' Academy
for Cardiovascular Education
Agenda
Topics
▼
Media
▼
Online-CME
News
▼
Meeting Reports
Slides
▼
About
ACC 2020
▼
AHA 2020
▼
Covid-19
▼
Diabetes & CVD
▼
ESC 2020
▼
HF Practical Tutorials
▼
Kidney disease & CVD
▼
PCSK9 inhibition: Clinical Update 2014
3' education - Oct. 29, 2014 - Snapshot 2014 - Dr Evan Stein
Dr. Evan Stein, Cincinnati, USA, with an overview of phase III data with the PCSK9 inhibitor evolocumab as were presented in 2014
Share this page with your colleagues and friends:
Share this page with your colleagues and friends: